Eli Lilly Pills - Search News

New weight loss pill to be approved by early 2026

Hosted on MSN · 18h

Eli Lilly CEO expects new weight loss pill to be approved next year

Eli Lilly and its rivals are working to develop more convenient options than the injectable Zepbound and Wegovy, which dominate the weight loss drug market.

YAHOO!Finance · 2d

Eli Lilly's weight loss pill could get federal approval by early next year

Eli Lilly & Co. ( LLY) thinks its next experimental weight-loss pill could get approved as soon as early 2026.

Quartz on MSN · 1d

Eli Lilly was hoping weight loss drug demand would be even bigger

Eli Lilly (LLY) revised its revenue outlook on Tuesday for the fourth quarter of 2024 on weaker-than-expected demand for its popular weight-loss drugs, Zepbound and Mounjaro.

1d

Eli Lilly misses 2024 revenue numbers, but GLP-1 pill may help

Global pharmaceutical company Eli Lilly's (LLY) preliminary 2024 revenue missed expectations on lower-than-expected sales of ...

Pfizer Cautiously Optimistic on Obesity Pill as Kailera Challenges Lilly’s Zepbound With Strong Phase II Data

Obesity continues to grab attention at the J.P. Morgan Healthcare Conference in San Francisco, with both Pfizer and Kailera ...

2don MSN

Lilly oral obesity drug could get FDA okay in early 2026: report

CEO Dave Ricks said Monday that the company's weight-loss pill orforglipron could receive FDA approval as soon as early 2026. Read more here.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results